.png)
Services
SVG Pharma provides structured clinical research services for medicinal cannabis and selected emerging therapeutics, supporting sponsors through compliant study design, execution, and reporting within Australia’s regulated research environment.
Scope & Focus
SVG Pharma works with sponsors developing therapies in areas where clinical precedent, regulatory expectations, and evidence pathways may still be evolving. Our focus is on supporting programs that require structured clinical planning, careful governance, and compliant execution within Australia’s regulatory and ethics framework.
​
Our role is to bring clarity and operational discipline to complex clinical programs—ensuring studies are clinically meaningful, ethically governed, and appropriately aligned with regulatory and research requirements.
Our Delivery Framework
Across all programs, SVG Pharma applies a consistent delivery framework to support quality, compliance, and informed decision-making.
​
1. Feasibility & Planning
Assessment of scientific rationale, regulatory context, and operational feasibility to define program viability and appropriate study scope.
​
2. Study Design & Governance
Protocol development, ethics and regulatory planning, and risk management aligned with TGA, HREC, and GCP expectations.
​
3. Trial Execution & Delivery
Structured study execution, oversight, and documentation, including controlled-substance regulatory considerations where applicable.
​
4. Analysis & Reporting​
Study outputs prepared to support informed clinical and development decision-making, with clear documentation and governance.
Australian Regulatory Context
SVG Pharma supports both Australian and international sponsors conducting clinical research in Australia. Programs are aligned with Australian regulatory and ethics frameworks and, where applicable, coordinated with global development strategies.